
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Dement Neuropsychol</journal-id><journal-id journal-id-type="iso-abbrev">Dement Neuropsychol</journal-id><journal-id journal-id-type="publisher-id">dn</journal-id><journal-title-group><journal-title>Dementia &#x00026; Neuropsychologia</journal-title></journal-title-group><issn pub-type="ppub">1980-5764</issn><publisher><publisher-name>Associa&#x000e7;&#x000e3;o de Neurologia Cognitiva e do
Comportamento</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29213708</article-id><article-id pub-id-type="pmc">5619069</article-id><article-id pub-id-type="doi">10.1590/S1980-57642010DN40400014</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Did you rule out neurosyphilis?</article-title><trans-title-group xml:lang="pt"><trans-title>Voc&#x000ea; excluiu neuross&#x000ed;filis?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nitrini</surname><given-names>Ricardo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>de Paiva</surname><given-names>Anderson Rodrigues Brand&#x000e3;o</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Takada</surname><given-names>Leonel Tadao</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Brucki</surname><given-names>Sonia Maria Dozzi</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1-4</label>MD, PhD, Behavioral and Cognitive Neurology Unit,
Department of Neurology, and Cognitive Disorders Reference Center (CEREDIC),
Hospital das Cl&#x000ed;nicas of the University of S&#x000e3;o Paulo School of
Medicine, S&#x000e3;o Paulo SP, Brazil.</aff><author-notes><corresp id="c1"><bold>Ricardo Nitrini</bold> &#x02013; Rua Itapeva, 378 / cj. 93 -
01332-000 S&#x000e3;o Paulo SP - Brazil. E-mail:
<email>rnitrini@uol.com.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Oct-Dec</season><year>2010</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2010</year></pub-date><volume>4</volume><issue>4</issue><fpage>338</fpage><lpage>345</lpage><history><date date-type="received"><day>10</day><month>7</month><year>2010</year></date><date date-type="accepted"><day>11</day><month>9</month><year>2010</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>Neurosyphilis, formerly a frequent cause of dementia, is now a rare condition in
developed countries. However, syphilis remains common in many developing
countries, where adequate diagnosis and treatment of early syphilis may be
lacking, increasing the chances of neurosyphilis and prevalence of syphilitic
dementia.</p><sec><title>Objectives</title><p>To present cases of syphilitic dementia seen in a cognitive and behavioral
neurology unit in Brazil, emphasizing their first symptoms and the
challenges they posed in diagnosis.</p></sec><sec><title>Methods</title><p>At our unit of the Hospital das Cl&#x000ed;nicas of the University of
S&#x000e3;o Paulo, all patients are submitted to blood treponemal tests. When
the test is positive, a lumbar puncture is performed. We retrospectivelly
reviewed all cases of neurosyphilis seen in our unit from January 1991 to
November 2009.</p></sec><sec><title>Results</title><p>Nine cases of neurosyphilis (0.77% of the 1160 cases in our files) were
identified over the period. Patients with neurosyphilis were all men, had a
mean age of 47.8 (&#x000b1;13.0) years (median of 43 years), and presented
with various neuropsychiatric syndromes and elusive diagnoses. The median
time from onset of symptoms to diagnosis was 24 months and only one patient
made a full recovery after treatment.</p></sec><sec><title>Conclusions</title><p>Neurosyphilis is not frequent but remains present, causing several types of
neuropsychiatric syndromes. As it is very simple to rule out neurosyphilis
by performing a blood treponemal test, this test should be performed in all
patients with neuropsychiatric symptoms, particularly in regions of the
world where syphilis is still a commonly occurring disease.</p></sec></abstract><trans-abstract xml:lang="pt"><p>Neuross&#x000ed;filis, anteriormente uma causa freq&#x000fc;ente de
dem&#x000ea;ncia, &#x000e9; atualmente rara nos pa&#x000ed;ses desenvolvidos. A
s&#x000ed;filis &#x000e9; ainda uma doen&#x000e7;a comum em muitos pa&#x000ed;ses em
desenvolvimento, onde o diagn&#x000f3;stico e tratamento da s&#x000ed;filis
precoce podem n&#x000e3;o ser adequados, o que aumenta a possibilidade de
ocorr&#x000ea;ncia de neuross&#x000ed;filis e de dem&#x000ea;ncia.</p><sec><title>Objetivos</title><p>apresentar casos de dem&#x000ea;ncia sifil&#x000ed;tica atendidos em uma
unidade de neurologia cognitiva e do comportamento no Brasil, enfatizando os
primeiros sintomas e os desafios que impuseram ao diagn&#x000f3;stico.</p></sec><sec><title>M&#x000e9;todos</title><p>Em nossa unidade do Hospital das Cl&#x000ed;nicas da Universidade de
S&#x000e3;o Paulo, todos os pacientes s&#x000e3;o submetidos a teste
trepon&#x000ea;mico no sangue. Quando o teste &#x000e9; positivo, &#x000e9;
realizada pun&#x000e7;&#x000e3;o lombar. Avaliamos retrospectivamente todos os
casos de neuross&#x000ed;filis atendidos em nossa unidade de janeiro de 1991
a novembro de 2009.</p></sec><sec><title>Resultados</title><p>Nove casos de neuross&#x000ed;filis (0,77% dos 1.160 casos de nossos arquivos)
foram identificados neste per&#x000ed;odo. Os pacientes com
neuross&#x000ed;filis eram todos homens, com idade m&#x000e9;dia de 47,8
(&#x000b1;13,0) anos (mediana de 43 anos), e apresentaram-se com
v&#x000e1;rios tipos de s&#x000ed;ndromes neuropsiqui&#x000e1;tricas, de
dif&#x000ed;cil diagn&#x000f3;stico. O tempo m&#x000e9;dio entre o
in&#x000ed;cio dos sintomas e o diagn&#x000f3;stico foi de 24 meses e apenas
um paciente teve recupera&#x000e7;&#x000e3;o completa ap&#x000f3;s o
tratamento.</p></sec><sec><title>Conclus&#x000f5;es</title><p>Neuross&#x000ed;filis n&#x000e3;o &#x000e9; frequente, mas ainda est&#x000e1;
presente causando v&#x000e1;rios tipos de s&#x000ed;ndromes
neuropsiqui&#x000e1;tricas. Como &#x000e9; muito simples excluir o
diagn&#x000f3;stico de neuross&#x000ed;filis mediante teste trepon&#x000ea;mico
no sangue, este teste deve ser realizado em todo paciente com sintomas
neuropsiqui&#x000e1;tricos, particularmente nas regi&#x000f5;es do mundo onde
a s&#x000ed;filis &#x000e9; ainda uma doen&#x000e7;a comum.</p></sec></trans-abstract><kwd-group><kwd>neurosyphilis</kwd><kwd>syphilis</kwd><kwd>dementia</kwd><kwd>neuropsychiatry</kwd><kwd>paretic neurosyphilis</kwd></kwd-group></article-meta></front><body><p>Neurosyphilis was probably the most common cause of dementia until the mid-twentieth
century, because syphilis was very frequent and there was no adequate treatment for
early syphilis. Thus, a proportion of cases evolved to late forms, when dementia of
neurosyphilis may occur. On the other hand, life expectancy was low, which meant that
the degenerative dementias that are more frequent after 65 years were much rarer than
today. The advent of penicillin changed this scenario, because penicillin is highly
effective in the treatment of early syphilis, limiting the spread of the disease and
preventing progression to late forms.<sup><xref rid="r1" ref-type="bibr">1</xref></sup></p><p>Amongst these late forms, dementia may occur in meningovascular neurosyphilis, which may
cause vascular dementia or hydrocephalus by blocking the transit of cerebrospinal fluid
(CSF). But the most frequent cause of syphilitic dementia is paretic neurosyphilis (or
<italic>dementia paralytica</italic>, or general paralysis of the insane or general
paresis). Paretic neurosyphilis occurs in about 5% of patients untreated for early
syphilis, usually from 10 to 25 years after the infection.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref></sup></p><p>In paretic neurosyphilis there is a chronic meningoencephalitis caused by the invasion of
brain parenchyma by <italic>Treponema pallidum</italic>. The most conspicuous findings
are cortical atrophy, most markedly in the anterior portions of the brain, thickening of
the meninges and enlargement of the ventricles. There may be strong lymphoplasmocytic
infiltrates in the meninges and its vessels, which accumulate forming a cuff in the
perivascular spaces of the brain. Variable degrees of proliferation of the intimal layer
with narrowing and occlusion of the vessel lumen are seen in small capillaries and
venules, which are probably responsible for the marked loss of neurons, astrogliosis and
microglial cells that occur in the cerebral cortex, cerebellum and basal
ganglia.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> In other cases, the
lymphoplasmocytic infiltrate is minor and the degenerative changes predominate with more
severe cortical atrophy.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> Treponemes
may be evident in the cortex in 25 to 40% of the cases,<sup><xref rid="r5" ref-type="bibr">5</xref></sup> and are more frequent in those cases where the
lymphoplasmocytic infiltrate is minor.<sup><xref rid="r4" ref-type="bibr">4</xref></sup></p><p>The efficacy of penicillin in the treatment of early syphilis reduced the frequency of
dementia caused by neurosyphilis in developed countries in such a way that in 2001 the
American Academy of Neurology guidelines for the diagnosis of dementia proposed that
screening for syphilis in all patients with dementia was no longer necessary.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> Dementia caused by neurosyphilis has
become so uncommon in the developing world that single cases are published as case
reports of rare causes of dementia, sometimes with challenging diagnosis because
neuropsyphilis is not regularly included amongst diagnostic hypotheses.<sup><xref rid="r7" ref-type="bibr">7</xref>-<xref rid="r9" ref-type="bibr">9</xref></sup></p><p>In Brazil, as well as in many other developing countries, syphilis is still a common
disease,<sup><xref rid="r10" ref-type="bibr">10</xref></sup> and adequate
diagnosis and treatment of early syphilis may be lacking, making syphilitic dementia
more frequent. In a multicenter study in Brazil, the prevalence of syphilis in patients
with mental illness was 1.12%.<sup><xref rid="r11" ref-type="bibr">11</xref></sup> The
Brazilian Academy of Neurology recommends screening for syphilis in the diagnosis of
dementia through use of blood tests.<sup><xref rid="r12" ref-type="bibr">12</xref></sup></p><p>Diagnosing syphilitic dementia demands a considerable degree of suspicion, particularly
in the initial phase, when treatment is more effective. When dementia is severe, the
chances of full recovery is low.<sup><xref rid="r13" ref-type="bibr">13</xref></sup></p><p>Our aims in this retrospective study were to present cases of patients with syphilitic
dementia assisted in a cognitive and behavioral neurology unit in S&#x000e3;o Paulo,
Brazil, emphasizing their first symptoms and the challenges they posed in diagnosis.</p><sec sec-type="methods"><title>Methods</title><p>At the Behavioral and Cognitive Neurology Unit of the Hospital das Cl&#x000ed;nicas of
the University of S&#x000e3;o Paulo, a public hospital, all patients are submitted to
blood tests for syphilis, including a treponemal test. When the treponemal test is
positive, a lumbar puncture is performed, and the diagnosis of neurosyphilis is
confirmed by positive VDRL and treponemal test in CSF. When only the treponemal test
is positive in the CSF, the diagnosis of neurosyphilis is still possible when there
is pleocytosis (&#x02265;5 cells/mm<sup>3</sup>) and/or slightly elevated protein
levels (45-200 mg/dL) with a high gammaglobulin proportion (&#x0003e;14%). All patients
with syphilis are tested for HIV infection.</p><p>We identified all patients with behavioral or cognitive disturbances caused by
neurosyphilis that were seen in our unit from January 1991 to November 2009.</p><p>The cases of neurosyphilis were analyzed with respect to demographic characteristics,
main symptoms and signs, duration of symptoms until diagnosis, neuropsychological
profile and exams. The classification of the forms of neurosyphilis into general
paresis, taboparesis or meningovascular syphilis was based on guidelines proposed by
Merritt et al.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> All patients were
treated with intravenous penicillin at high doses and treatment outcomes were
evaluated.</p><p>This study was approved by the Research Ethics Committee of the Hospital das
Cl&#x000ed;nicas of the University of S&#x000e3;o Paulo, Brazil.</p></sec><sec sec-type="results"><title>Results</title><p>In this 19-year period, 1,160 patients (54.6% women) presenting cognitive or
behavioral disturbances, with a mean age of 68.3 (&#x000b1;11.6) years and 5.6
(&#x000b1;4.6) years of schooling, were assisted at our unit. Nine cases of
neurosyphilis (0.77%) were identified in this period. Patients with neurosyphilis
were all men, had a mean age of 47.8 (&#x000b1;13.0) years (median of 43 years), and
8.8 (&#x000b1;6.6) years of schooling (median of 8 years of schooling). Demographic
data and diagnoses are shown in <xref ref-type="table" rid="t1">Table 1</xref>.
Median time to diagnosis from onset of symptoms was 24 months. Seven cases were
diagnosed as paretic neurosyphilis, one with taboparesis (paretic neurosyphilis with
tabetic signs) and one case as meningovascular neurosyphilis.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographic data, diagnoses and time to diagnosis.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Case/Year </th><th align="center" rowspan="1" colspan="1">Gender</th><th align="center" rowspan="1" colspan="1">Age </th><th align="center" rowspan="1" colspan="1">Education(years of schooling)</th><th align="center" rowspan="1" colspan="1">Diagnosis (clinical syndrome)</th><th align="center" rowspan="1" colspan="1">Time to diagnosis (months)</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1/1991&#x000a0; </td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">PN</td><td align="center" rowspan="1" colspan="1">36</td></tr><tr><td align="center" rowspan="1" colspan="1">2/1993</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">61</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">PN</td><td align="center" rowspan="1" colspan="1">17</td></tr><tr><td align="center" rowspan="1" colspan="1">3/1994</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">PN</td><td align="center" rowspan="1" colspan="1">12</td></tr><tr><td align="center" rowspan="1" colspan="1">4/1997</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">MV</td><td align="center" rowspan="1" colspan="1">24</td></tr><tr><td align="center" rowspan="1" colspan="1">5/1997</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">PN</td><td align="center" rowspan="1" colspan="1">12</td></tr><tr><td align="center" rowspan="1" colspan="1">6/1995</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">TP</td><td align="center" rowspan="1" colspan="1">6</td></tr><tr><td align="center" rowspan="1" colspan="1">7/2000</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">PN</td><td align="center" rowspan="1" colspan="1">24</td></tr><tr><td align="center" rowspan="1" colspan="1">8/2000</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">PN</td><td align="center" rowspan="1" colspan="1">48</td></tr><tr><td align="center" rowspan="1" colspan="1">9/2003</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">71</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">PN</td><td align="center" rowspan="1" colspan="1">36</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>MV: meningovascular neurosyphilis; PN: paretic neurosyphilis; TP:
taboparesis.</p></fn></table-wrap-foot></table-wrap><p>One patient (case 4) reported a history of syphilis. The neurological examination
disclosed hyperactive deep reflexes in six cases (cases 1,2,3,4,5,9) dysarthria in
four cases (cases 1,3,4,8), hemiparesis in three (cases 2,5,6), and absence of the
light reflex with an active reaction in accommodation (Argyll Robertson pupil) in
two cases (cases 1, 6). One patient (case 9) had parkinsonian signs. Beyond the
cognitive and behavioral abnormalities, the neurological examination did not
disclose other signs in one patient (case 7), while subtle signs were seen in cases
1 and 8.</p><p>Serum and CSF tests are shown in <xref ref-type="table" rid="t2">Table 2</xref>. All
patients had positive non-treponemal tests (VDRL or Wassermann&#x02019;s test) in the CSF
and eight presented with pleocytosis.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>First blood tests and cerebrospinal fluid (CSF) examinations.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="1%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/></colgroup><thead><tr><th align="center" rowspan="2" colspan="1">Case</th><th style="border-bottom-width:thin;border-bottom-style:solid" align="center" colspan="2" rowspan="1">Serum</th><th align="center" rowspan="2" colspan="1">&#x000a0;</th><th style="border-bottom-width:thin;border-bottom-style:solid" align="center" colspan="5" rowspan="1">CSF</th></tr><tr><th align="center" rowspan="1" colspan="1">VDRL</th><th align="center" rowspan="1" colspan="1">Trep. T.</th><th align="center" rowspan="1" colspan="1">Leukoc/mm<sup>3</sup></th><th align="center" rowspan="1" colspan="1">Protein (mg/dl)</th><th align="center" rowspan="1" colspan="1">Gammagl. (%)</th><th align="center" rowspan="1" colspan="1">VDRL</th><th align="center" rowspan="1" colspan="1">TPHA</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">1/8</td><td align="center" rowspan="1" colspan="1">TPHA + (&#x0003e;1/1024)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">76</td><td align="center" rowspan="1" colspan="1">49.7</td><td align="center" rowspan="1" colspan="1">1/8</td><td align="center" rowspan="1" colspan="1">&#x0003e;1/1024</td></tr><tr><td align="center" rowspan="1" colspan="1">2 </td><td align="center" rowspan="1" colspan="1">1/16</td><td align="center" rowspan="1" colspan="1">FTA-Abs +</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">64</td><td align="center" rowspan="1" colspan="1">20.3</td><td align="center" rowspan="1" colspan="1">1/4</td><td align="center" rowspan="1" colspan="1">&#x0003e;1/1024</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">FTA-Abs +</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">58</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">26.3</td><td align="center" rowspan="1" colspan="1">WR 1/4</td><td align="center" rowspan="1" colspan="1">1/512</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">FTA-Abs +</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">98</td><td align="center" rowspan="1" colspan="1">31.3</td><td align="center" rowspan="1" colspan="1">1/4</td><td align="center" rowspan="1" colspan="1">+</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">FTA-Abs +</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">42.6</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">+</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">1/8</td><td align="center" rowspan="1" colspan="1">TPHA + (1/256) </td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">35.9</td><td align="center" rowspan="1" colspan="1">1/2</td><td align="center" rowspan="1" colspan="1">1/256</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">1/32</td><td align="center" rowspan="1" colspan="1">FTA-Abs +</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">165</td><td align="center" rowspan="1" colspan="1">127</td><td align="center" rowspan="1" colspan="1">31.8</td><td align="center" rowspan="1" colspan="1">WR+</td><td align="center" rowspan="1" colspan="1">1/512</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">NR</td><td align="center" rowspan="1" colspan="1">ELISA +</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">39.6</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">1/512</td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">1/256</td><td align="center" rowspan="1" colspan="1">TPHA +</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">133</td><td align="center" rowspan="1" colspan="1">206</td><td align="center" rowspan="1" colspan="1">33.9</td><td align="center" rowspan="1" colspan="1">1/128</td><td align="center" rowspan="1" colspan="1">+</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>ELISA: Enzyme linked immunoassay; FTA-Abs: fluorescent treponemal
antibody-absorbed; Gammagl.: gammaglobulin; Leukoc: leukocytes; NA: not
available; NR: Non reactive; WR: Wassermann's reaction; TPHA: Treponema
pallidum haemagglutination assay.</p></fn></table-wrap-foot></table-wrap><p><xref ref-type="table" rid="t3">Table 3</xref> contains a summary of the initial
symptoms, the presumptive or first diagnostic hypothesis, and outcome after
treatment with intravenous penicillin from 18 to 24 million IU for 10 to 21 days.
Only one case made a full recovery, returning to his previous professional
activities. In most cases there was a partial recovery or the condition was
considered to be unchanged when the progression of the disease was halted without
significant improvement.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Initial symptoms, first diagnostic hypothesis, Mini-Mental State Exam (MMSE)
and outcome.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1%" span="1"/><col width="19%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="center" valign="bottom" rowspan="1" colspan="1">Case</th><th align="left" valign="bottom" rowspan="1" colspan="1">Initial symptoms</th><th align="center" valign="bottom" rowspan="1" colspan="1">First diagnosticHypothesis</th><th align="center" valign="bottom" rowspan="1" colspan="1">Initial MMSE score</th><th align="center" valign="bottom" rowspan="1" colspan="1">Outcome</th><th align="center" valign="bottom" rowspan="1" colspan="1">Highest MMSE score after
treatment</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Persecutory delusions,&#x000a0; auditory hallucinations and
epileptic seizures</td><td align="center" rowspan="1" colspan="1">Psychosis, schizophrenia</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">Unchanged </td><td align="center" rowspan="1" colspan="1">22</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">"Meningoencephalitis", memory decline, topographical
disorientation</td><td align="center" rowspan="1" colspan="1">Herpetic encephalitis</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">Unchanged </td><td align="center" rowspan="1" colspan="1">19</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Irritability, motor and psychic slowness</td><td align="center" rowspan="1" colspan="1">"Organic" disorder</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">Partial improvement </td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">Tremors, seizures, memory decline</td><td align="center" rowspan="1" colspan="1">Cerebrovascular disease</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">Partial improvement</td><td align="center" rowspan="1" colspan="1">23</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">Forgetfulness, dysexecutive syndrome, seizures</td><td align="center" rowspan="1" colspan="1">Dementia not specified</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">Unchanged</td><td align="center" rowspan="1" colspan="1">25</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Agressivity, memory decline, collecting behavior</td><td align="center" rowspan="1" colspan="1">Dementia not specified</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">Partial improvement</td><td align="center" rowspan="1" colspan="1">25</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">Memory decline, topographical disorientation, social
inadequacy</td><td align="center" rowspan="1" colspan="1">Alzheimer's disease</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">Full recovery</td><td align="center" rowspan="1" colspan="1">27</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">Irritability, social withdrawal, dysexecutive
syndrome</td><td align="center" rowspan="1" colspan="1">Frontotemporal dementia</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">Unchanged</td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">Delirium, tremors, memory decline, topographical
disorientation</td><td align="center" rowspan="1" colspan="1">Dementia with Lewy bodies</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">Partial improvement</td><td align="center" rowspan="1" colspan="1">13</td></tr></tbody></table></table-wrap><p><xref ref-type="table" rid="t4">Table 4</xref> summarizes neuroimaging data.
Vignettes of the nine cases are presented in the appendix.</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Neuroimaging findings.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="2%" span="1"/><col width="24%" span="1"/><col width="24%" span="1"/></colgroup><thead><tr><th align="center" valign="bottom" rowspan="1" colspan="1">Case</th><th align="left" valign="bottom" rowspan="1" colspan="1">Computed tomography
(CT)<break/>Magnetic resonance imaging (MRI)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Single Photon computed tomography
(SPECT)</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Slight hypoperfusion in the left fronto-parietal
cortex</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">CT: Normal</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">MRI: Cortical atrophy, more severe in the right
hemisphere</td><td align="left" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">CT: Multiple infarcts (larger infarct in the right
temporoparietal area)</td><td align="left" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">MRI: Diffuse cortico-subcortical atrophy and infarct in
the right temporal lobe</td><td align="left" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">CT: Diffuse cortico-subcortical atrophy</td><td align="left" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">CT: Diffuse cortico-subcortical atrophy</td><td align="left" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">MRI: Diffuse cortico-subcortical atrophy</td><td align="left" rowspan="1" colspan="1">Slight hypoperfusion in the frontal cortex.</td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">MRI: Diffuse cortico-subcortical atrophy</td><td align="left" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>NA: not available.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>Our findings show that syphilitic dementia still occurs in our country, albeit at a
much lower frequency compared to levels reported before penicillin became
available.<sup><xref rid="r2" ref-type="bibr">2</xref></sup></p><p>All patients in this series were men. Syphilis, and particularly neurosyphilis, has
always been more frequent in men since its first descriptions. In the past, syphilis
was considered to be more common in men because they were infected by women
prostitutes, with many men being infected by a few prostitutes.<sup><xref rid="r14" ref-type="bibr">14</xref></sup> More recently, syphilis has been
more frequent in men who have sex with other men.<sup><xref rid="r15" ref-type="bibr">15</xref></sup> Syphilis and neurosyphilis have also been more
frequent in HIV+ patients.<sup><xref rid="r16" ref-type="bibr">16</xref></sup> In
this series, none of the patients were HIV+, probably because there is a referral
bias, with HIV+ patients being assisted in other departments of our hospital.</p><p>There are several aspects that need to be stressed. Most of our patients were younger
than 50 years old and can be classified as young-onset dementia.<sup><xref rid="r17" ref-type="bibr">17</xref></sup> The time from the initial symptoms
to the diagnosis of neurosyphilis (median of 24 months) was very long. This may be
in part explained by the protean early symptoms. The presumptive diagnoses were
diverse, ranging from schizophrenia to herpetic encephalitis, with many cases being
attributed to degenerative or unspecified causes. Neurosyphilis has been long
recognized as a &#x0201c;great imitator&#x0201d;,<sup><xref rid="r18" ref-type="bibr">18</xref></sup> and the clinical diagnosis can be very difficult because &#x0201c;pure
psychiatric cases&#x0201d; may be found or other diagnoses may be entertained.</p><p>Previous history of syphilis is rarely obtained in these cases, and in this study,
only one patient reported a history of syphilis. The neurological examination may
show hyperactive deep reflexes, hemiparesis, dysarthria, pupillary abnormalities and
absence of the light reflex, and even parkinsonian signs. In this series, &#x0201c;somatic&#x0201d;
neurological examination was normal in only one patient, with only subtle signs in
two.</p><p>Neuroimaging, the most important subsidiary exam for the diagnosis of dementia, may
be misleading in paretic neurosyphilis because the diffuse atrophy may be suggestive
of degenerative dementia.<sup><xref rid="r19" ref-type="bibr">19</xref></sup> In
this small series, five cases had CT or MRI showing diffuse cortico-subcortical
atrophy without other findings.</p><p>In a study performed in New Orleans, Louisiana, USA, the authors reviewed all cases
of neurosyphilis seen in a university hospital from 1998 to 2001. Cases with
positive-HIV serology were excluded. They found 17 cases of neurosyphilis, with mean
age of 49.7 (&#x000b1;12.0) years. Neuropsychiatric symptoms were frequent (four
presented with violent behavior, six were disoriented, and four had memory
deficits).<sup><xref rid="r20" ref-type="bibr">20</xref></sup></p><p>As evidenced, neurosyphilis is not a rare disease, but its diagnosis may be very
elusive. However, it is easy to rule out this diagnosis using blood tests. Serum
VDRL may be non reactive in neurosyphilis, but a negative treponemal test (FTA-Abs:
fluorescent treponemal antibody-absorbed or TPHA: <italic>Treponema
pallidum</italic> haemagglutination assay or ELISA: Enzyme linked immunoassay)
virtually excludes syphilis.<sup><xref rid="r19" ref-type="bibr">19</xref></sup> If
serum treponemal antibody test is reactive in a suspected case of neurosyphilis,
lumbar puncture is mandatory. A non-reactive treponemal test in the CSF virtually
excludes neurosyphilis. Although the CSF-treponemal tests have high sensitivity,
their specificity is not high, as a reactive test may be due to diffusion of
antibodies from the serum. When a CSF-treponemal test is reactive, the diagnosis of
neurosyphilis is supported by reactive CSF-VDRL, which is highly specific, though
false reactive CSF-VDRL may occur when there is blood in the CSF or when the
blood-brain barrier is severely breached. However, as its sensitivity is relatively
low, false negative CSF-VDRL tests may occur in neurosyphilis.<sup><xref rid="r16" ref-type="bibr">16</xref></sup>, <sup><xref rid="r19" ref-type="bibr">19</xref></sup> When the CSF treponemal test is reactive and the
CSF-VDRL is non-reactive, diagnosis of neurosyphilis is supported by pleocytosis
(&#x02265;5 cells/mm<sup>3</sup>), slightly elevated protein (45-200 mg/dL) with
elevated CSF-IgG. The diagnosis may be particularly difficult in patients with HIV-1
infection because slight pleocytosis and elevated protein in the CSF are also common
in this condition. Given that syphilis is common in HIV-infected individuals, a
reactive FTA-Abs test in the CSF could be caused by diffusion from the serum, in the
absence of neurosyphilis. If a patient with possible paretic neurosyphilis has a
reactive CSF-treponemal test and pleocytosis or elevated protein concentration, even
if the CSF-VDRL is negative, treatment for neurosyphilis should be given.<sup><xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r19" ref-type="bibr">19</xref></sup> This is particularly relevant for patients with HIV-1
infection.<sup><xref rid="r16" ref-type="bibr">16</xref></sup></p><p>In our cases, serum VDRL was non-reactive in one case whereas serum and CSF
treponemal tests were reactive in all patients. CSF-VDRL was reactive in all cases
in which it was performed (7 cases). In the other two patients, VDRL was substituted
by the Wassermann&#x02019;s complement fixation test, which was reactive in both cases
(<xref ref-type="table" rid="t2">Table 2</xref>). Pleocytosis was present in
seven cases and high concentration of protein in the CSF in eight cases. A very high
proportion of gammaglobulins (&#x0003e;30%), which are mostly IgG, was found in seven
cases. High levels of IgG is a frequent finding in neurosyphilis, particularly in
paretic dementia.<sup><xref rid="r21" ref-type="bibr">21</xref></sup></p><p>All patients were treated with intravenous penicillin G for 10 to 21 days. In our
service we treat patients with severe forms of neurosyphilis with 24 million
international units of penicillin G for 21 days. In this series, a few patients that
came to our service after recent treatment had received intravenous penicillin for
10 to 14 days. All patients were followed-up with lumbar puncture repeated at
6-month intervals for 2 to 3 years. No cases had persistent pleocytosis, and no
patients were re-treated with antibiotics for neurosyphilis.</p><p>In neurosyphilis, significant clinical improvement occurs mainly when the treatment
is administered in the first few months after the onset of the mental disturbances,
particularly in mild and moderate disturbances.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r13" ref-type="bibr">13</xref></sup> In our series
however, only one patient returned to his previous professional activity whereas
most patients became dependent on others or were able to work only in less demanding
activities. This may be explained by the long delay reaching diagnosis, in a
condition where the diagnosis is so simple, when only a blood treponemal test need
be performed.</p><p>The main conclusions of this paper are:</p><p><list list-type="simple"><list-item><p>[i] neurosyphilis is not frequent but it is still present, causing many
types of neuropsychiatric syndromes, from schizophreniform psychotic
syndrome to dementia mimicking Alzheimer&#x02019;s disease;</p></list-item><list-item><p>[ii] as it is very simple to rule out neurosyphilis by performing a blood
treponemal test, this test should be performed in all patients with
neuropsychiatric symptoms, particularly in regions of the world where
syphilis is still a common disease.</p></list-item></list></p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>Disclosure: The authors report no conflicts of interest.</p></fn></fn-group><ref-list><title>References</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nitrini</surname><given-names>R</given-names></name></person-group><article-title>The cure of one of the most frequent types of dementia: a
historical parallel</article-title><source>Alzheimer Dis Assoc Disord</source><year>2005</year><volume>19</volume><fpage>156</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">16118533</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Merritt</surname><given-names>HH</given-names></name><name><surname>Adams</surname><given-names>RD</given-names></name><name><surname>Solomon</surname><given-names>HC</given-names></name></person-group><source>Neurosyphilis</source><year>1946</year><publisher-loc>York, New York</publisher-loc><publisher-name>New York, Oxford University Press New</publisher-name></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname><given-names>RD</given-names></name><name><surname>Webster</surname><given-names>B</given-names></name><name><surname>Weickhardt</surname><given-names>G</given-names></name><etal/></person-group><article-title>The results of treatment in 1,086 general paralytics the majority
of whom were followed for more than five years</article-title><source>J Chronic Dis</source><year>1958</year><volume>7</volume><fpage>209</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">13539135</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miklossy</surname><given-names>J</given-names></name></person-group><article-title>Biology and neuropathology of dementia in syphilis and lyme
disease</article-title><source>Handb Clin Neurol</source><year>2008</year><volume>89</volume><fpage>825</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">18631798</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hook III</surname><given-names>EW</given-names></name></person-group><chapter-title>Central Nervous System Syphilis</chapter-title><person-group person-group-type="editor"><name><surname>Scheld</surname><given-names>WM</given-names></name><name><surname>Whitley</surname><given-names>RJ</given-names></name><name><surname>Durack</surname><given-names>DT</given-names></name></person-group><source>Infections of the central nervous system</source><publisher-name>Raven Press, Ltd.</publisher-name><publisher-loc>New York</publisher-loc><year>1991</year><volume>27</volume><fpage>639</fpage><lpage>655</lpage></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>DeKosky</surname><given-names>ST</given-names></name><name><surname>Cummings</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Practice parameter: diagnosis of dementia (an evidence-based
review): report of the Quality Standards Subcommittee of the American
Academy of Neurology</article-title><source>Neurology</source><year>2001</year><volume>56</volume><fpage>1143</fpage><lpage>1153</lpage><pub-id pub-id-type="pmid">11342678</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Wilck</surname><given-names>M</given-names></name><name><surname>Venna</surname><given-names>N</given-names></name></person-group><article-title>Dementia due to neurosyphilis with persistently negative CSF
VDRL</article-title><source>Neurology</source><year>2005</year><volume>65</volume><fpage>1838</fpage><lpage>1838</lpage><pub-id pub-id-type="pmid">16344539</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Lin</surname><given-names>WC</given-names></name><name><surname>Lu</surname><given-names>CH</given-names></name><name><surname>Liu</surname><given-names>JW</given-names></name></person-group><article-title>Initially unrecognized dementia in a young man with
neurosyphilis</article-title><source>Neurologist</source><year>2009</year><volume>15</volume><fpage>95</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">19276787</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000fc;ler</surname><given-names>E</given-names></name><name><surname>Leyhe</surname><given-names>T</given-names></name></person-group><article-title>A late form of neurosyphilis manifesting with psychotic symptoms
in old age and good response to ceftriaxone therapy</article-title><source>Int Psychogeriatr</source><year>2010</year><volume>15</volume><fpage>1</fpage><lpage>4</lpage></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Global prevalence and incidence of selected curable sexually transmitted
infections: overview and estimates</source><year>2001</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guimar&#x000e3;es</surname><given-names>MD</given-names></name><name><surname>Campos</surname><given-names>LN</given-names></name><name><surname>Melo</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Prevalence of HIV, syphilis, hepatitis B and C among adults with
mental illness: a multicenter study in Brazil</article-title><source>Rev Bras Psiquiatr</source><year>2009</year><volume>31</volume><fpage>43</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">19506775</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nitrini</surname><given-names>R</given-names></name><name><surname>Caramelli</surname><given-names>P</given-names></name><name><surname>Bottino</surname><given-names>CM</given-names></name><name><surname>Damasceno</surname><given-names>BP</given-names></name><name><surname>Brucki</surname><given-names>SM</given-names></name><name><surname>Anghinah</surname><given-names>R</given-names></name></person-group><article-title>Diagnosis of Alzheimer's disease in Brazil: diagnostic criteria
and auxiliary tests: recommendations of the Scientific Department of
Cognitive Neurology and Aging of the Brazilian Academy of
Neurology</article-title><source>Arq Neuropsiquiatr</source><year>2005</year><volume>63</volume><fpage>713</fpage><lpage>719</lpage><pub-id pub-id-type="pmid">16172732</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Storm-Mathisen</surname><given-names>A</given-names></name></person-group><chapter-title>Syphilis</chapter-title><person-group person-group-type="editor"><name><surname>Vinken</surname><given-names>PJ</given-names></name><name><surname>Bruyn</surname><given-names>GW</given-names></name></person-group><source>Infections of the Nervous System, part I. Handbook of Clinical
Neurology</source><year>1978</year><volume>33</volume><fpage>337</fpage><lpage>394</lpage><publisher-loc>Amsterdam</publisher-loc><publisher-name>Elsevier</publisher-name></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>F</given-names></name><name><surname>Pacheco-Silva</surname><given-names>AC</given-names></name></person-group><article-title>A dem&#x000ea;ncia paralytica em S&#x000e3;o Paulo</article-title><source>Arq Brasil Neuriat Psiquiat</source><year>1924</year><volume>6</volume><fpage>1</fpage><lpage>22</lpage></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahn</surname><given-names>RH</given-names></name><name><surname>Heffelfinger</surname><given-names>JD</given-names></name><name><surname>Berman</surname><given-names>SM</given-names></name></person-group><article-title>Syphilis outbreaks among men who have sex with men: a public
health trend of concern</article-title><source>Sex Transm Dis</source><year>2002</year><volume>29</volume><fpage>285</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">11984445</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marra</surname><given-names>CM</given-names></name></person-group><article-title>Update on neurosyphilis</article-title><source>Curr Infect Dis Rep</source><year>2009</year><volume>11</volume><fpage>127</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">19239803</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossor</surname><given-names>MN</given-names></name><name><surname>Fox</surname><given-names>NC</given-names></name><name><surname>Mummery</surname><given-names>CJ</given-names></name><name><surname>Schott</surname><given-names>JM</given-names></name><name><surname>Warren</surname><given-names>JD</given-names></name></person-group><article-title>The diagnosis of young-onset dementia</article-title><source>Lancet Neurol</source><year>2010</year><volume>9</volume><fpage>793</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">20650401</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Synnott</surname><given-names>IH</given-names></name></person-group><article-title>The great imitator</article-title><source>Med J Aust</source><year>1988</year><volume>148</volume><fpage>105</fpage><lpage>105</lpage></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nitrini</surname><given-names>R</given-names></name></person-group><article-title>Clinical and therapeutic aspects of dementia in syphilis and lyme
disease</article-title><source>Handb Clin Neurol</source><year>2008</year><volume>89</volume><fpage>819</fpage><lpage>823</lpage><pub-id pub-id-type="pmid">18631797</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lair</surname><given-names>L</given-names></name><name><surname>Naidech</surname><given-names>AM</given-names></name></person-group><article-title>Modern neuropsychiatric presentation of
neurosyphilis</article-title><source>Neurology</source><year>2004</year><volume>63</volume><fpage>1331</fpage><lpage>1334</lpage><pub-id pub-id-type="pmid">15477572</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nitrini</surname><given-names>R</given-names></name><name><surname>Spina-Fran&#x000e7;a</surname><given-names>A</given-names></name></person-group><article-title>High-dose intravenous penicillin therapy in neurosyphilis: study
of 62 cases. II. Evaluation of cerebrospinal fluid</article-title><source>Arq Neuropsiquiatr</source><year>1987</year><volume>45</volume><fpage>231</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">2449879</pub-id></element-citation></ref></ref-list></back></article>